Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Amisulpride (DAN 2163) (trade name Solian) is an antipsychotic drug sold by Sanofi-Aventis. It is not approved for use in the United States, but is approved for use in Europe and Australia for the treatment of psychoses and schizophrenia. Additionally, it is approved in Italy for the treatment of dysthymia (under the brand name Deniban). Amisulpride is a selective dopamine antagonist.
パッケージサイズ | 在庫状況 | 単価(税別) | |||
---|---|---|---|---|---|
サンプルについてお問い合わせ | |||||
25 mg | 在庫あり | ¥ 10,000 | |||
50 mg | 在庫あり | ¥ 13,500 | |||
100 mg | 在庫あり | ¥ 18,500 | |||
200 mg | 在庫あり | ¥ 32,000 | |||
500 mg | 在庫あり | ¥ 58,000 | |||
1 g | 在庫あり | ¥ 85,500 | |||
1 mL * 10 mM (in DMSO) | 在庫あり | ¥ 9,000 |
説明 | Amisulpride (DAN 2163) (trade name Solian) is an antipsychotic drug sold by Sanofi-Aventis. It is not approved for use in the United States, but is approved for use in Europe and Australia for the treatment of psychoses and schizophrenia. Additionally, it is approved in Italy for the treatment of dysthymia (under the brand name Deniban). Amisulpride is a selective dopamine antagonist. |
ターゲット&IC50 | D3 receptor:3.2 nM (Ki), D2 receptor:2.8 nM (Ki) |
別名 | DAN 2163 |
分子量 | 369.48 |
分子式 | C17H27N3O4S |
CAS No. | 71675-85-9 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Ethanol: 65 mg/mL(175.9 mM)
H2O: < 1 mg/mL (insoluble or slightly soluble)
DMSO: 74 mg/mL (200.28 mM)
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Amisulpride 71675-85-9 GPCR/G Protein Neuroscience Dopamine Receptor 5-HT Receptor DAN 2163 Inhibitor inhibit DAN2163 DAN-2163 inhibitor